POWELL, Jonathan, Davie;HEIKAMP, Emily, Beth;THE JOHNS HOPKINS UNIVERSITY
发明人:
POWELL, Jonathan, Davie,HEIKAMP, Emily, Beth
申请号：
USUS2012/038252
公开号：
WO2012/158866A9
申请日:
2012.05.17
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The present invention provides novel methods for treating Th2-mediated immune disorders and enhancing Th1-mediated immune responses in a subject comprising administering to the subject, a pharmaceutical composition comprising a serum-glucocorticoid regulated kinase 1 (SGK1) inhibitor and a pharmaceutically acceptable carrier. Methods for treating a wide range of autoimmune diseases are also taught. The present invention also provides methods for augmenting the treatment of subjects having viral or parasitic infections, or which have cancerous tumors.
